{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:02:36Z","timestamp":1791385356345,"version":"4.3.3"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1I1A306969914"],"award-info":[{"award-number":["2020R1I1A306969914"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115953","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T18:49:47Z","timestamp":1764614987000},"page":"115953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Modern trends of using innovative nanoparticle approaches for immune-based osteosarcoma therapy"],"prefix":"10.1016","volume":"168","author":[{"given":"Sana","family":"Kausar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Ja","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115953_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.5435\/00124635-200908000-00005","article-title":"Osteosarcoma","volume":"17","author":"Messerschmitt","year":"2009","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.intimp.2025.115953_bb0010","series-title":"Osteosarcoma (Osteogenic Sarcoma)","author":"Greenwood","year":"2024"},{"key":"10.1016\/j.intimp.2025.115953_bb0015","first-page":"1","article-title":"Identification of potential genes associated with metastasis in osteosarcoma: an integrated bioinformatics analysis","author":"Wiratnaya","year":"2025","journal-title":"Musculoskelet. Surg."},{"key":"10.1016\/j.intimp.2025.115953_bb0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0031-3955(05)70540-X","article-title":"Osteosarcoma","volume":"44","author":"Meyers","year":"1997","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.intimp.2025.115953_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12938-021-00860-0","article-title":"Osteosarcoma: a review of current and future therapeutic approaches","volume":"20","author":"Zhao","year":"2021","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.intimp.2025.115953_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2025.115953_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115953_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0050","doi-asserted-by":"crossref","first-page":"2400323","DOI":"10.1002\/adhm.202400323","article-title":"Mesoporous silica nanoparticles as an ideal platform for Cancer immunotherapy: recent advances and future directions","volume":"20","author":"Godakhindi","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.intimp.2025.115953_bb0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/D1NH00179E","article-title":"Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy","volume":"9","author":"Chung","year":"2021","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.intimp.2025.115953_bb0060","doi-asserted-by":"crossref","first-page":"2307299","DOI":"10.1002\/smll.202307299","article-title":"Advances in immunomodulatory MOFs for biomedical applications","volume":"20","author":"Zhang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.intimp.2025.115953_bb0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10856-013-5113-0","article-title":"Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin","volume":"25","author":"Shi","year":"2014","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.intimp.2025.115953_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041489","article-title":"Advancements in nanoparticles-based therapeutic approaches for osteosarcoma: insights from catechins-modified selenium-doped hydroxyapatite: a review","volume":"104","author":"Degang","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2025.115953_bb0075","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/acsnano.2c03573","article-title":"Live macrophage-delivered doxorubicin-loaded liposomes effectively treat triple-negative breast cancer","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.115953_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116488","article-title":"Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma","volume":"244","author":"Musalli","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.intimp.2025.115953_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acsbiomedchemau.1c00021","article-title":"Stable gold-nanoparticle-based vaccine for the targeted delivery of tumor-associated glycopeptide antigens","volume":"1","author":"Trabbic","year":"2021","journal-title":"ACS Bio Med. Chem. Au"},{"key":"10.1016\/j.intimp.2025.115953_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10989-023-10523-4","article-title":"Recent research progress of RGD peptide\u2013modified nanodrug delivery systems in tumor therapy","volume":"29","author":"Yin","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.intimp.2025.115953_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110147","article-title":"In-vivo anticancer efficacy of self-targeted methotrexate-loaded polymeric nanoparticles in solid tumor-bearing rat","volume":"119","author":"Verma","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115953_bb0100","series-title":"Nanotechnology Based Microbicides and Immune Stimulators","first-page":"19","article-title":"Immunomodulatory nanoparticles and their advancement in health","author":"Saba","year":"2022"},{"key":"10.1016\/j.intimp.2025.115953_bb0105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/pharmaceutics12111054","article-title":"Liposome-based drug delivery systems in cancer immunotherapy","volume":"12","author":"Gu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.115953_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2025.115953_bb0115","doi-asserted-by":"crossref","first-page":"41758","DOI":"10.1021\/acsami.9b16848","article-title":"Accelerated bone regeneration by gold-nanoparticle-loaded mesoporous silica through stimulating immunomodulation","volume":"11","author":"Liang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.intimp.2025.115953_bb0120","doi-asserted-by":"crossref","first-page":"25400","DOI":"10.1021\/acsanm.4c04294","article-title":"Doxorubicin-and selenium-incorporated mesoporous silica nanoparticles as a combination therapy for osteosarcoma","volume":"7","author":"He","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.intimp.2025.115953_bb0125","doi-asserted-by":"crossref","first-page":"25400","DOI":"10.1021\/acsanm.4c04294","article-title":"Doxorubicin-and selenium-incorporated mesoporous silica nanoparticles as a combination therapy for osteosarcoma","volume":"7","author":"He","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.intimp.2025.115953_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.07.007","article-title":"Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors","volume":"119","author":"Ojha","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2025.115953_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.115953_bb0140","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acsnano.0c09681","article-title":"Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy","volume":"15","author":"Hu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.115953_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2025.115953_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-025-03394-8","article-title":"Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy","volume":"44","author":"Imani","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0155","series-title":"Precision Medicine in Oncology","author":"Aydogan","year":"2020"},{"key":"10.1016\/j.intimp.2025.115953_bb0160","doi-asserted-by":"crossref","unstructured":"Ghidini M, Silva SG, Evangelista J, do Vale ML, Farooqi AA, Pinheiro M. Nanomedicine for the delivery of RNA in cancer. Cancers 2022;14:2677.","DOI":"10.3390\/cancers14112677"},{"key":"10.1016\/j.intimp.2025.115953_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121502","article-title":"Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor","volume":"284","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2025.115953_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12951-023-01966-4","article-title":"Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2025.115953_bb0175","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1021\/acs.molpharmaceut.2c00611","article-title":"Co-delivery of doxorubicin and anti-PD-L1 peptide in lipid\/PLGA nanocomplexes for the chemo-immunotherapy of cancer","volume":"19","author":"Zhang","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2025.115953_bb0180","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/21691401.2019.1608219","article-title":"Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA","volume":"47","author":"Chen","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115953_bb0185","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115953_bb0190","doi-asserted-by":"crossref","first-page":"1024143","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles\u2014promising carriers for cancer therapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115953_bb0195","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3390\/pharmaceutics15071868","article-title":"Gold nanoparticles: construction for drug delivery and application in cancer immunotherapy","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.115953_bb0200","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1002\/anie.202101938","article-title":"Improving bioavailability of hydrophobic prodrugs through supramolecular nanocarriers based on recombinant proteins for osteosarcoma treatment","volume":"60","author":"Wang","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.intimp.2025.115953_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/wnan.1364","article-title":"Polymeric nanoparticles: the future of nanomedicine","volume":"8","author":"Banik","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2025.115953_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7150\/jca.36588","article-title":"Recent advances of drug delivery nanocarriers in osteosarcoma treatment","volume":"11","author":"Wang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2025.115953_bb0215","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C7BM00008A","article-title":"Recent advances in carbon based nanosystems for cancer theranostics","volume":"5","author":"Augustine","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.intimp.2025.115953_bb0220","doi-asserted-by":"crossref","first-page":"2100539","DOI":"10.1002\/smtd.202100539","article-title":"An efficient carbon-based drug delivery system for cancer therapy through the nucleus targeting and mitochondria mediated apoptotic pathway","volume":"5","author":"Zhang","year":"2021","journal-title":"Small Methods"},{"key":"10.1016\/j.intimp.2025.115953_bb0225","doi-asserted-by":"crossref","first-page":"3631764","DOI":"10.1155\/2016\/3631764","article-title":"Osteosarcoma: cells-of-origin, cancer stem cells, and targeted therapies","volume":"2016","author":"Abarrategi","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.intimp.2025.115953_bb0230","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.3390\/ijms24076615","article-title":"Liposomes in cancer therapy: how did we start and where are we now","volume":"24","author":"Fulton","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2025.115953_bb0235","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.75774","article-title":"Dendrimers as drug nanocarriers: the future of gene therapy and targeted therapies in cancer","volume":"25","author":"Franiak-Pietryga","year":"2018","journal-title":"Dendrimers Fundam Appl."},{"key":"10.1016\/j.intimp.2025.115953_bb0240","first-page":"1","article-title":"Advancing brain immunotherapy through functional nanomaterials. Drug Deliv","author":"Yalamandala","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.707319","article-title":"Stimuli-responsive polymeric nanoplatforms for cancer therapy","volume":"9","author":"Chang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115953_bb0250","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1039\/D1CS00427A","article-title":"Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer","volume":"50","author":"Gavil\u00e1n","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115953_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jare.2010.02.002","article-title":"Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy","volume":"1","author":"Huang","year":"2010","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0260","series-title":"Emerging Nanotechnologies in Dentistry","first-page":"347","article-title":"Carbon nanotubes in cancer therapy and drug delivery","author":"Elhissi","year":"2012"},{"key":"10.1016\/j.intimp.2025.115953_bb0265","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367(6478):eaau6977","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115953_bb0270","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.2147\/IJN.S388430","article-title":"How efficient are alendronate-nano\/biomaterial combinations for anti-osteoporosis therapy?An evidence-based review","volume":"17","author":"Klara","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.intimp.2025.115953_bb0275","doi-asserted-by":"crossref","first-page":"E4601","DOI":"10.1073\/pnas.1603316113","article-title":"Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis","volume":"113","author":"Yin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2025.115953_bb0280","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/vaccines11040835","article-title":"T cell based immunotherapy for cancer: approaches and strategies","volume":"11","author":"Want","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2025.115953_bb0285","doi-asserted-by":"crossref","first-page":"1057850","DOI":"10.3389\/fimmu.2022.1057850","article-title":"Modulating the tumor immune microenvironment with nanoparticles: a sword for improving the efficiency of ovarian cancer immunotherapy","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115953_bb0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","article-title":"T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution","volume":"43","author":"Yang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/cancers15010009","article-title":"Ifosfamide-loaded PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in osteosarcoma","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2025.115953_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/1538-7445.AM2022-307","article-title":"Ponatinib loaded leukocyte-based nanoparticles: a new platform for treating osteosarcoma","volume":"82","author":"Giordano","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115953_bb0305","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2018.12.008","article-title":"Design strategies for shape-controlled magnetic iron oxide nanoparticles","volume":"138","author":"Roca","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2025.115953_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.162","article-title":"The efficacy and safety of pegylated liposomal doxorubicin-based neoadjuvant chemotherapy in children with osteosarcoma: a retrospective real-world study","volume":"4","author":"Wang","year":"2025","journal-title":"Cancer Innov."},{"key":"10.1016\/j.intimp.2025.115953_bb0315","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3390\/ijms22115760","article-title":"Curcumin-loaded nanoparticles impair the pro-tumor activity of acid-stressed MSC in an in vitro model of osteosarcoma","volume":"22","author":"Di Pompo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115953_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101335","article-title":"Theranostic nanoparticles with disease-specific administration strategies","volume":"42","author":"Zhang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.intimp.2025.115953_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-024-04163-w","article-title":"Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment","volume":"20","author":"Benjamin","year":"2025","journal-title":"Discover Nano."},{"key":"10.1016\/j.intimp.2025.115953_bb0330","doi-asserted-by":"crossref","first-page":"1703969","DOI":"10.1002\/adma.201703969","article-title":"Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity","volume":"29","author":"Kroll","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2025.115953_bb0335","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab4241","article-title":"Magnetic nanoparticles in nanomedicine: a review of recent advances","volume":"30","author":"Wu","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.intimp.2025.115953_bb0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115953_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110891","article-title":"Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma","volume":"190","author":"Huang","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.intimp.2025.115953_bb0350","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.115953_bb0355","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115953_bb0360","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1039\/C5CS00499C","article-title":"Understanding and exploiting nanoparticles\u2019 intimacy with the blood vessel and blood","volume":"44","author":"Setyawati","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.intimp.2025.115953_bb0365","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2025.115953_bb0370","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2025.115953_bb0375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.115953_bb0380","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.intimp.2025.115953_bb0385","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1021\/jacs.9b13813","article-title":"Biodegradable gold nanoclusters with improved excretion due to pH-triggered hydrophobic-to-hydrophilic transition","volume":"142","author":"Higbee-Dempsey","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.intimp.2025.115953_bb0390","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.115953_bb0395","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/anie.201705019","article-title":"From precision synthesis of block copolymers to properties and applications of nanoparticles","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.intimp.2025.115953_bb0400","doi-asserted-by":"crossref","first-page":"1700030","DOI":"10.1002\/marc.201700030","article-title":"Stimuli-responsive polymeric nanoparticles","volume":"38","author":"Liu","year":"2017","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.intimp.2025.115953_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.986223","article-title":"Aggregation behavior of nanoparticles: revisiting the phase diagram of colloids","volume":"9","author":"Bini","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.intimp.2025.115953_bb0410","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C6BM00921B","article-title":"Personalized protein corona on nanoparticles and its clinical implications","volume":"5","author":"Corbo","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.intimp.2025.115953_bb0415","doi-asserted-by":"crossref","first-page":"1801350","DOI":"10.1002\/adma.201801350","article-title":"Photosensitizers with aggregation-induced emission: materials and biomedical applications","volume":"30","author":"Hu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2025.115953_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102162","article-title":"Nanoparticle processing: understanding and controlling aggregation","volume":"279","author":"Shrestha","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.intimp.2025.115953_bb0425","article-title":"Development and evaluation of nanocarriers of \u03b2-lactoglobulin for drug delivery: a comparative study of protein-based nanoparticle, nanofiber, and nanotube","volume":"1\u201324","author":"Ahadi-Amandi","year":"2025","journal-title":"Polym. Bull."},{"key":"10.1016\/j.intimp.2025.115953_bb0430","first-page":"1","article-title":"pH-sensitive macromolecular carriers: targeted therapeutics for cancer and inflammation. Journal of macromolecular","volume":"Part B","author":"Singh","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115953_bb0435","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jconrel.2024.06.055","article-title":"Nanoparticle-mediated thermal cancer therapies: strategies to improve clinical translatability","volume":"372","author":"Bravo","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.115953_bb0440","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1039\/C5TB01741F","article-title":"Exosome-inspired targeting of cancer cells with enhanced affinity","volume":"4","author":"Hosseini","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.intimp.2025.115953_bb0445","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/dna.2024.0245","article-title":"Exosome-delivered Hsa_Circ_0000116 facilitates osteosarcoma cell malignancy via PI3K\/Akt\/mTOR and p38\/MAPK pathways","volume":"44","author":"Gao","year":"2025","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.intimp.2025.115953_bb0450","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1007\/s12274-018-2066-0","article-title":"Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas","volume":"11","author":"Zhang","year":"2018","journal-title":"Nano Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115953_bb0455","article-title":"Extracellular vesicles in cancer drug resistance: mechanistic insights and therapeutic implications","volume":"3","author":"Zuo","year":"2024","journal-title":"MedComm - Oncol"},{"key":"10.1016\/j.intimp.2025.115953_bb0460","article-title":"Advances in stabilization of metallic nanoparticle with biosurfactants \u2013 a review on current trends","volume":"10","author":"Kamalesh","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2025.115953_bb0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115953_bb0470","doi-asserted-by":"crossref","unstructured":"Liu Y, Hardie J, Zhang X, Rotello VM. Effects of engineered nanoparticles on the innate immune system. In: Seminars in Immunology, Elsevier, pp. 25\u201332.","DOI":"10.1016\/j.smim.2017.09.011"},{"key":"10.1016\/j.intimp.2025.115953_bb0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2020.04.026","article-title":"Tumor microenvironment-induced structure changing drug\/gene delivery system for overcoming delivery-associated challenges","volume":"323","author":"Zhang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.115953_bb0480","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.actbio.2019.09.009","article-title":"Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: a review","volume":"101","author":"Thakkar","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2025.115953_bb0485","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2016.04.009","article-title":"Targeting tumor microenvironment in cancer therapy","volume":"380","author":"Singh","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115953_bb0490","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-013-1434-6","article-title":"Immune-suppressive properties of the tumor microenvironment","volume":"62","author":"Becker","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2025.115953_bb0495","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018026009","article-title":"Nanoparticles in daily life: applications, toxicity and regulations","volume":"37","author":"Gupta","year":"2018","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.intimp.2025.115953_bb0500","doi-asserted-by":"crossref","first-page":"1271321","DOI":"10.3389\/fphar.2023.1271321","article-title":"Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115953_bb0505","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12951-023-01826-1","article-title":"Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics","volume":"21","author":"Shi","year":"2023","journal-title":"J. Nanobiotechnol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:12:14Z","timestamp":1777619534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925019411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":101,"alternative-id":["S1567576925019411"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115953","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern trends of using innovative nanoparticle approaches for immune-based osteosarcoma therapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115953"}}